- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Basic earnings per share of Sanofi 2009-2018
Basic earnings per share of Sanofi 2009-2018
Basic earning's per Sanofi's shares from 2009 to 2018 (in euros)
by Matej Mikulic,
last edited
Mar 11, 2019
This statistic shows Sanofi's basic earnings per share from 2009 to 2018. In 2009, Sanofi's basic earnings per share totaled some 4.03 euros. Sanofi is one of the top global pharmaceutical companies. It is headquartered in Paris, France.
Basic earning's per Sanofi's shares from 2009 to 2018 (in euros)
Loading statistic...
| Earnings per share in euros | |
|---|---|
| 2018 | 3.45 |
| 2017 | 6.7 |
| 2016 | 3.66 |
| 2015 | 3.28 |
| 2014 | 3.34 |
| 2013 | 2.81 |
| 2012 | 3.71 |
| 2011 | 4.31 |
| 2010 | 4.19 |
| 2009 | 4.03 |
| Earnings per share in euros | |
|---|---|
| 2018 | 3.45 |
| 2017 | 6.7 |
| 2016 | 3.66 |
| 2015 | 3.28 |
| 2014 | 3.34 |
| 2013 | 2.81 |
| 2012 | 3.71 |
| 2011 | 4.31 |
| 2010 | 4.19 |
| 2009 | 4.03 |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Mar 11, 2019
This statistic shows Sanofi's basic earnings per share from 2009 to 2018. In 2009, Sanofi's basic earnings per share totaled some 4.03 euros. Sanofi is one of the top global pharmaceutical companies. It is headquartered in Paris, France.
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- March 2019
- Region
- Worldwide
- Survey time period
- 2009 to 2018
- Supplementary notes
- Figures prior to 2016 were taken from previous editions.
Source
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- March 2019
More information
- Region
- Worldwide
- Survey time period
- 2009 to 2018
- Supplementary notes
- Figures prior to 2016 were taken from previous editions.
Other statistics on the topic
+Pharmaceutical Products & Market
Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
+Pharmaceutical Products & Market
Top 10 biotech and pharmaceutical companies based on market cap 2019
+Pharmaceutical Products & Market
Sanofi top pharmaceutical products 2017-2018
Pharmaceutical Products & Market
Revenue of Sanofi 2006-2018
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Sanofi
- 47 page/s
- English
- pptx
- Detailed references
Everything On "Sanofi" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Sanofi"
- Global positioning
The most important statistics
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2019
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- Top 10 pharmaceutical companies based on global prescription drug revenue in 2024 (in billion U.S. dollars)*Total global prescription drug revenue from top 10 companies 2024
- Top 5 global vaccine products by market share in 2017 and 2024Leading global vaccine products by market share 2017 and 2024
- Top animal health mergers and acquisitions worldwide between 2014 and 2018, by enterprise value (in million U.S. dollars)Top global mergers and acquisitions in animal health 2014-2018, by enterprise value
- Overview
The most important statistics
- Revenue of Sanofi from 2006 to 2018 (in million euros)Revenue of Sanofi 2006-2018
- Sanofi's selected top pharmaceutical products based on revenue in 2017 and 2018 (in million euros)Sanofi top pharmaceutical products 2017-2018
- Sanofi's net income from 2007 to 2018 (in million euros)*Sanofi's net income 2007-2018
- Sanofi's expenditure on research and development from 2008 to 2018 (in million euros)Sanofi's expenditure on research and development 2008-2018
- Sanofi's total assets from 2007 to 2018 (in million euros)Sanofi's total assets 2007-2018
- Sanofi's number of employees from 2009 to 2018Sanofi number of employees 2009-2018
- Revenue distribution
The most important statistics
- Revenue of Sanofi by region in 2018 (in million euros)Sanofi revenue by region 2018
- Revenue of Sanofi by segment from 2014 to 2018 (in million euros)Sanofi - revenue by segment 2014-2018
- Revenue of Sanofi's pharmaceutical segment by product group from 2015 to 2018 (in million euros)Sanofi - pharmaceutical segment revenues by product group 2015-2018
- Sanofi's human vaccine revenues from 2016 to 2018, by area of application (in million euros)Sanofi: human vaccine revenues 2016-2018
- Revenue of Sanofi 's Animal Health segment from 2012 to 2016 (in million euros)Sanofi - revenue of animal health segment 2012-2016
- Company shares
The most important statistics
- Number of Sanofi's outstanding shares from 2009 to 2018 (in millions)Average number of outstanding shares of Sanofi 2009-2018
- Basic earning's per Sanofi's shares from 2009 to 2018 (in euros)Basic earnings per share of Sanofi 2009-2018
- Cash dividend per share of Sanofi from 2009 to 2018 (in euros)*Cash dividend per share of Sanofi 2009-2018
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Sanofi Aventis SA: number of employees in Spain 2010-2016
- Sanofi Aventis SA: sales value 2012-2016
- Medicine spending share globally in 2007,2017 and 2023, by country group
- Peak sales per new pharmaceutical asset 2010-2018
- Pharma revenue share worldwide 2017, by country
- Price increase of geriatric drugs in the U.S. in 2017, by manufacturer
- Number of opioid marketing payments U.S. in 2013-2015, by census region
- Mean cost of U.S. opioid marketing as of 2015, by census region
- Poultry diagnostics market size U.S. by test type 2015-2025
- Number of injection drug shortages in Canada 2013-2016, by company
- Sales of top multinational pharmaceutical companies in China in Q1 2011
- Pricing of orphan drugs across three countries on annual basis 2016
- Number of injection drugs that had shortages in Canada in 2013-2016, by company
- Enterprise value of players in oncology rare disease therapeutics 2017
- U.S. costs saved through generics by therapy 2004-2013
- Forecast: revenue optical instrument manufacture Belgium 2010-2020
- Share of PAT margin of Indian company Cipla 2013-2018
- McKesson Europe's revenue 2018 by country
- Neste's sales 2018, by region
- DDI market share worldwide 2011-2015, by vendor
Statistics on "Sanofi"
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)
- Top 10 pharmaceutical companies based on global prescription drug revenue in 2024 (in billion U.S. dollars)*
- Top 5 global vaccine products by market share in 2017 and 2024
- Top animal health mergers and acquisitions worldwide between 2014 and 2018, by enterprise value (in million U.S. dollars)
- Revenue of Sanofi from 2006 to 2018 (in million euros)
- Sanofi's selected top pharmaceutical products based on revenue in 2017 and 2018 (in million euros)
- Sanofi's net income from 2007 to 2018 (in million euros)*
- Sanofi's expenditure on research and development from 2008 to 2018 (in million euros)
- Sanofi's total assets from 2007 to 2018 (in million euros)
- Sanofi's number of employees from 2009 to 2018
- Revenue of Sanofi by region in 2018 (in million euros)
- Revenue of Sanofi by segment from 2014 to 2018 (in million euros)
- Revenue of Sanofi's pharmaceutical segment by product group from 2015 to 2018 (in million euros)
- Sanofi's human vaccine revenues from 2016 to 2018, by area of application (in million euros)
- Revenue of Sanofi 's Animal Health segment from 2012 to 2016 (in million euros)
- Number of Sanofi's outstanding shares from 2009 to 2018 (in millions)
- Basic earning's per Sanofi's shares from 2009 to 2018 (in euros)
- Cash dividend per share of Sanofi from 2009 to 2018 (in euros)*
- Number of Sanofi Aventis SA employees in Spain from 2010 to 2016
- Annual sales value of Sanofi Aventis SA in Spain from 2012 to 2016 (in million euros)
- Global medicine spending distribution in 2007, 2018 and 2023, by country group
- Peak sales for each new pharmaceutical asset from 2010 to 2018, by study cohort (in million U.S. dollars)
- Share of pharmaceutical revenue worldwide in 2017, by country
- Average price increase of brand name drugs widely used by older adults in the U.S. as of 2017, by manufacturer*
- Number of opioid marketing payments made to U.S. doctors in 2013-2015, by census region (per 1,000 population)
- Mean cost of U.S. opioid pharmaceutical marketing per 1,000 population in 2013-2015, by census region (in U.S. dollars)
- Poultry diagnostics market in the U.S. from 2015 to 2025, by test type (in million U.S. dollars)*
- Number of injectable drug shortages in Canada from 2013 to 2016, by company*
- Sales of the leading multinational pharmaceutical companies in China during the 1st quarter 2011 (in million U.S. dollars)
- Selected annual-based orphan drug prices compared in UK, U.S., and Australia as of 2016 (in U.S. dollars)*
- Number of injectable drugs that experienced shortages in Canada from 2013 to 2016, by company*
- Enterprise value of leading pure players in oncology rare disease therapeutics worldwide as of 2017 (in million U.S. dollars)*
- Distribution of cost savings through generics in the United States in the period 2004-2013, by therapeutic area
- Revenue of optical instrument manufacture (NACE Rev. 2 C2670) in Belgium from 2010 to 2020 (in million U.S. dollars)
- Share of PAT margin of Cipla Limited in India from FY 2014 to FY 2018*
- Revenue of McKesson Europe in 2018, by country (in million euros)
- Distribution of sales of Neste as of 2018, by region
- Share of the DDI (DNS, DHCP, and IPAM) market worldwide from 2011 to 2015, by vendor
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.